# A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes

> **NCT03309007** · PHASE3 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 25 (actual)

## Conditions studied

- PreDiabetes
- Aging

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03309007
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2020-08-20
- **Final completion:** 2020-08-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03309007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03309007, "A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03309007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*